About

Louise Nash has a wide ranging corporate practice including mergers and acquisitions, joint ventures and collaborations and private equity (including venture capital). Her practice is…

Louise Nash has a wide ranging corporate practice including mergers and acquisitions, joint ventures and collaborations and private equity (including venture capital). Her practice is international, with virtually all transactions upon which she advises having a cross-border dimension. As such, she has extensive experience of dealing with the challenges presented by complex cross-border projects. She has particular experience in the branded goods, life science and technology sectors and in advising on deals with a significant intellectual property element.

Latest Post

In this blog post we set out key practical steps for technology-focused deal-making, having regard to the regulatory, antitrust and foreign investment screening issues identified in our earlier blogs here and here.

Key impacts of technology regulation on deal outcomes

The evolving regulatory landscape is having a significant impact on deal outcomes, including (i) longer timelines due to complex regulatory approval requirements; (ii) higher diligence burden, especially around data, AI and ownership transparency; (iii) greater risk allocation pressure in deal terms; and (iv) increased use of creative structures to mitigate regulatory exposure. 

About

Louise Nash has a wide ranging corporate practice including mergers and acquisitions, joint ventures and collaborations and private equity (including venture capital). Her practice is…

Louise Nash has a wide ranging corporate practice including mergers and acquisitions, joint ventures and collaborations and private equity (including venture capital). Her practice is international, with virtually all transactions upon which she advises having a cross-border dimension. As such, she has extensive experience of dealing with the challenges presented by complex cross-border projects. She has particular experience in the branded goods, life science and technology sectors and in advising on deals with a significant intellectual property element.

Subscribe: Subscribe via RSS